Efficacy and Safety of Switching Patients Inadequately Controlled on Basal Insulin to Insulin Glargine 300 U/mL: The TRANSITION 2 Study
Crossref DOI link: https://doi.org/10.1007/s13300-019-00734-8
Published Online: 2019-11-28
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gourdy, Pierre http://orcid.org/0000-0002-5362-3813
Bahloul, Amar
Boultif, Zahra
Gouet, Didier
Guerci, Bruno
Funding for this research was provided by:
Sanofi Pasteur
Article History
Received: 18 October 2019
First Online: 28 November 2019